<code id='2865EDD3FC'></code><style id='2865EDD3FC'></style>
    • <acronym id='2865EDD3FC'></acronym>
      <center id='2865EDD3FC'><center id='2865EDD3FC'><tfoot id='2865EDD3FC'></tfoot></center><abbr id='2865EDD3FC'><dir id='2865EDD3FC'><tfoot id='2865EDD3FC'></tfoot><noframes id='2865EDD3FC'>

    • <optgroup id='2865EDD3FC'><strike id='2865EDD3FC'><sup id='2865EDD3FC'></sup></strike><code id='2865EDD3FC'></code></optgroup>
        1. <b id='2865EDD3FC'><label id='2865EDD3FC'><select id='2865EDD3FC'><dt id='2865EDD3FC'><span id='2865EDD3FC'></span></dt></select></label></b><u id='2865EDD3FC'></u>
          <i id='2865EDD3FC'><strike id='2865EDD3FC'><tt id='2865EDD3FC'><pre id='2865EDD3FC'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:15
          Nvidia
          Sipa via AP Images

          SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear.

          The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P. Morgan Healthcare Conference, and describing why it thinks AI, running on Nvidia computers, could dramatically increase the number of new medicines that are created while reducing their cost, ushering in an age of “digital biology.”

          advertisement

          When Kimberly Powell, Nvidia’s vice president of health care, finished her presentation, the room erupted in applause.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers
          Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

          AdobeWhenitcomestobringinganexperimentaldrugtomarketandsellingit,NovoNordisk,themakeroftheweightloss

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          New requirements coming in 2024 for Americans traveling to Europe

          4:04ThecoverofaU.S.PassportisdisplayedinTigard,Ore.,Dec.11,2021.JennyKane/AP,FILEAnyonelookingtotrav